Acute promyelocytic leukemia (APL) is characterized by a block in myeloid cell dierentiation. As a result of a chromosomal translocation in these patients, the promyelocytic leukemia protein PML is disrupted as are the nuclear bodies it forms. Disruption of PML and PML nuclear bodies in APL is linked to a loss of growth control and subsequent leukemogenesis. PML contains a zinc-binding domain known as the RING which is required for formation of these bodies. Using yeast 2-hybrid techniques, we found that PML and a related RING protein, Z, bind the proline rich homeodomain protein (PRH) through their RING domains. Previous reports indicate that PRH functions in hematopoiesis and may act as a transcriptional repressor. Our data indicate that PML and Z both bind the repressor domain of PRH and are the ®rst protein partners reported for PRH. We observe that PRH has a punctate pattern in both the nucleus and cytoplasm of chronic myelogenous leukemia K562 cells and in the APL cell line, NB4. Immunoprecipitation and co-localization studies indicate that PML and PRH interact in both cell lines. The eect on cell growth by PML and the hematopoietic actions of PRH raises the possibility that the interaction between PML and PRH represents a link between growth control and hematopoiesis.
Introduction
Hematopoiesis is a carefully controlled process by which progenitor cells mature in a highly regulated manner. Dysregulation of this process can contribute to leukemogenesis. Acute promyelocytic leukemia (APL), which comprises about 10% of myeloid leukemias, is characterized by a block in myeloid cell dierentiation at the promyelocyte stage (reviewed in Melnick and Licht, 1999) . In APL, the promyelocytic leukemia (PML) protein is fused to the retinoic acid receptor alpha (RARA) due to a chromosomal translocation. The PML-RARA fusion protein can bind both wild-type PML and RARA resulting in a dominant phenotype. Hence, the nuclear organelle which PML forms, PML nuclear bodies, are disrupted forming a microparticulate pattern in the nucleus and cytoplasm. Pro-apoptotic and growth suppressive functions were attributed to PML and may be linked to the integrity of these bodies (Wang et al., 1998; Quignon et al., 1998; Borden et al., 1997; Rogaia et al., 1995; Ferrucci et al., 1997; Mu et al., 1994) .
PML nuclear bodies are observed in all cell lines reported except hepatocarcinoma cells and are distinct from other nuclear organelles (reviewed in Melnick and Licht, 1999) . PML nuclear bodies are altered by pathogenic conditions including APL and viral infection. The composition of PML bodies is heterogeneous with several components present only in some bodies (Carlile et al., 1998; Borden et al., 1998b; LaMorte et al., 1998) . PML associates with over 15 proteins including factors involved in RNA transport, transcription and some ribosomal components (Melnick and Licht, 1999) . Notably absent from nuclear bodies is RNA polymerase II, DNA and TFIIH (Grande et al., 1996; Melnick and Licht, 1999) . Apart from nuclear bodies, PML is found as a soluble component in the nucleus and in cytoplasmic bodies (Flenghi et al., 1995; Fagioli et al., 1992) .
PML contains three cysteine-rich zinc-binding domains known as the RING, B-boxes (B1 and B2) and a leucine coiled-coil domain which form the RBCC motif (Saurin et al., 1996) . The RBCC motif is present in the PML-RARA fusion protein and in all PML isoforms. The RING motif appears in over 80 proteins including proto-oncoproteins such as PML, the breast cancer gene product BRCA1 and cytoplasmic proteins including peroxisomal proteins (Saurin et al., 1996) . RINGs are involved in protein interactions, probably do not bind nucleic acids directly and are often involved in macromolecular assemblages. Consistent with this possibility, PML nuclear bodies are disrupted if any of the zinc-binding residues in the RING or Bboxes are mutated (Borden et al., 1995 Le et al., 1996) . One 90 residue RING protein from an arenavirus, Z, associates with PML nuclear bodies, binds directly to PML, and can translocate bodies to the cytoplasm (Borden et al., 1998a) . Previous reports show that RING proteins can bind other RING proteins through this domain (e.g. Tanimura et al., 1999; Meza et al., 1999) . Others report that the RING can bind ubiquitin like molecules and ubiquitin hydrolase molecules (Jensen et al., 1998) . The sequence and structural diversity of the family suggest that RING binding domains (RBD) may be as diverse as the RING motif itself.
PML and Z RING domains are critical for several functions of these proteins. PML is involved in growth regulation at least in part through its RING. PML can suppress transformation and mutations which disrupt the RING disrupt this activity (Mu et al., 1994) . Overexpression of PML or Z in serum starved murine ®broblasts induces cell death and this activity is mediated in part through the RING (Borden et al., 1997) . In some cell types, overexpression of PML-RARA has potent growth inhibitory and apoptotic eects and these eects required the RBCC domains (Rogaia et al., 1995; Ferrucci et al., 1997) . Disruption of PML nuclear bodies through mutations in the RING domain correlates with a loss of its growth suppression (Le et al., 1996) , and apoptotic activities (Borden et al., 1997) .
The functional importance of the RING to PML indicates that any domains which bind to the RING and modulate its activity could have wide ranging eects on the fate of the cell. Thus, we carried out studies to ®nd protein partners for the RING. Partners were selected by using the yeast 2-hybrid system to screen a human chronic myelogenous leukemia K562 cDNA library (Lozzio and Lozzio, 1975; Tabilio et al., 1983) . We determined that the proline-rich homeodomain protein PRH, also known as hematopoietically expressed homeodomain Hex, was one of three interacting clones. PRH was of particular interest because previous studies suggested that dysregulation of PRH function leads to leukemogenesis (Mani®oletti et al., 1995; Tanaka et al., 1999) . We demonstrated that PRH associates with the RING domains of PML or Z through its proline-rich region. Our data describe the interaction between PML and PRH in K562 cells and in APL patient derived NB4 cells. This is the ®rst report of any protein partners for PRH. We discuss the possible biological consequences for these interactions in APL and during hemorrhagic fever induced by arenavirus infection.
Results
The Proline-Rich Homeodomain (PRH) interacts with PML and Z In order to ®nd proteins which interact with the RING domain of PML, a construct containing only the RING was prepared to use in a yeast 2-hybrid screen. Unfortunately, in single transformation experiments, this construct autoactivated. Thus, we used the Z protein, where 60 of its 90 residues is a RING domain.
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6 yeast organisms transformed with the K562 derived cDNA library were screened for interaction with Z using standard methods (Fields and Song, 1989) . Three positive clones that grew on leu-, trp-, hisplates and exhibited b-galactosidase (b-gal) activity were isolated. Sequence analysis and a data base search of GenBank using BLAST (Altschul et al., 1990) indicate that one of these clones was PRH and that the full-length cDNA was isolated. Yeast were cotransformed with constructs to show interaction between Z & PRH (Figure 1a, #1 ). Separate cotransformations established that PRH interacted with PML ( Figure 1a, #3) . Results are summarized in Figure 1a . Plasmids encoding the DNA binding protein SNF1 fused to GAL4 and the activation domain of SNF1 to GAL4 served as positive controls (Figure 1a, #15 ; Petter et al., 1997; Celenza et al., 1989) . The PML/PRH and Z/PRH interactions are speci®c as co-transformation with the unrelated construct SNF (Figure 1a , #8 ± 10) had no b-gal activity. b-gal activity was quanti®ed using standard methods and is shown in Figure 1b .
The RING is required for interaction with PRH We used the yeast system to map the interactions between Z & PRH and PML & PRH. Constructs used are given in Figure 2 . Both colorometric and liquid culture assays were used to monitor results ( Figure  1a,b) . For both PML and Z point mutations which caused misfolding of the RING domain (Borden et al., 1995 (Borden et al., , 1998a , denoted PMLRING and ZRING, abrogated the ability of either protein to bind PRH. Other regions of PML were deleted to determine if they were necessary for the interaction. Constructs used included deletion of B-boxes (PML-Bbox), leucine coiled coil (PML-coil), or C-terminal regions including the serine/proline rich region (PML-Cterm and PMLXma). For PML, disruption of other regions of the protein, including the leucine coiled coil and B-box motifs, did not aect its ability to bind PRH indicating that these domains were not required for interaction. Western and immuno¯uorescence analysis con®rmed that PML, Z and PRH mutants used were produced to levels similar to respective wild-type proteins (Borden et al., 1995 (Borden et al., , 1998a ; data not shown).
The region of PRH required for binding to PML or Z was determined. PRH contains three domains: an Nterminal proline-rich region, a central homeodomain and a C-terminal acidic region. Deletion mapping of PRH indicated that 65 amino acids in the N-terminal proline-rich region of PRH were required for the association of PRH to either PML or Z. This 65 residue region from residues 50 ± 115 appears to de®ne at least part of a novel RING binding domain (RBD) (Figure 1c) . This region has a 17% proline content and no characteristic domains. Further study will need to be carried out to determine if this region is sucient for RING binding. A search of GenBank revealed that there were no sequence homologies to this region outside of PRH proteins from other species. This domain is completely distinct from previously reported RBDs.
Z physically associates with PRH
In vitro co-immunoprecipitation studies were carried out to con®rm that PRH and Z interact (Figure 3 ). Hemagglutinin (HA) tagged PRH was immunopuri®ed from transformed yeast using the HA antibody. SDS ± PAGE analysis indicated that the PRH produced in this manner was pure (data not shown). Puri®ed Z protein, produced as described (Borden et al., 1998a) , was added to either protein A sepharose with either HA antibody only or PRH-HA antibody complexes and precipitated. Precipitates were loaded onto SDS ± PAGE, and stained with Coomassie blue. Z co-puri®ed with PRH-HA protein A beads but not in the absence of PRH. Precipitation of Z and identity of PRH were con®rmed by Western analysis using antibodies to anity puri®ed Z (Borden et al., 1998a) and to HA for PRH detection. This demonstrates that Z associates directly with PRH.
PRH protein is expressed in K562 and NB4 cells
To determine if PML and PRH interact in cell culture, we decided to initiate immunoprecipitation and colocalization studies. To observe endogenous PRH, we produced an antibody to the PRH protein the speci®city of which was assessed. Increasing amounts of a PRH construct were transfected into HeLa cells, which do not normally express PRH (Figure 4 ). In addition, this construct contained a FLAG tag. Total cell lysates were prepared, subjected to SDS ± PAGE and blotted. Identical Western blots were prepared and probed with either anti FLAG or PRH antibodies. As expected, no PRH signal is observed in the untransfected lanes. In both blots, higher levels of PRH protein are observed in cells transfected with more PRH construct. Further, the band observed is at the expected molecular weight for PRH. The major signal on the blot probed with anti FLAG antibody is in the identical position to that with the PRH antibody indicating that both antibodies detect the same protein.
Untransfected cells have a minor FLAG positive band present at a lower molecular weight than observed for the PRH-FLAG signal. This band fades as more PRH gene is transfected and the higher migrating band which aligns with PRH is only present in lanes 2 ± 10 where the PRH gene has been transfected and not in lane 1, the untransfected lane. The identity of the faster migrating species with the FLAG antibody is unknown; however, the PRH antibody does not detect this band. Hence, the PRH antibody detects the PRH protein speci®cally.
Using Western analysis, we determined that PRH was expressed in K562 cells and in the APL patient cell line NB4. Figure 4 shows total cell lysates probed with PRH antibody. PRH is expressed as a single band at the expected molecular weight (*30 kDa). Addition of all trans retinoic acid (ATRA) to NB4 cells results in reformation of PML nuclear bodies and remission in patients (Melnick and Licht, 1999 ). Thus we determined the eect of ATRA on PRH levels. Treatment with 1 mM ATRA for 2 days does not signi®cantly alter PRH protein levels (data not shown). Western analysis using the appropriate pre-immune sera does not reveal any bands (adjacent panel, Figure 4b ).
PML and PRH interact in K562 cells
Since we determined the PML PRH interaction in yeast, we investigated whether PRH and PML interacted in cell culture to con®rm the biological signi®cance of the interaction and to demonstrate that PRH and PML physically associated. K562 cells express both PML and PRH. K562 cell lysates were precipitated with a PRH polyclonal antibody and subsequent Western blots were probed for PML with a monoclonal antibody mAb PGM3 (Figure 5a ). We show that PML co-puri®ed with PRH in these experiments. In the complementary experiment, the lysates were immunoprecipitated with another monoclonal antibody to PML, mAb 5E10 (Stuurman et al., 1992) , and subsequent Western blots were probed for Figure 4 PRH protein expression. The given amount of PRH construct containing a FLAG tag was transfected in HeLa cells, which do not normally express PRH. Western blots were probed with either the PRH antibody or the anti-FLAG antibody as indicated. NT indicates not transfected. In the lower panel, total cell lysates from NB4 or K562 cells were subjected to SDS ± PAGE and probed with the anti-PRH antibody (PRH) or with pre-immune serum (P.I.) from the appropriate rabbit as indicated Subsequent blots were probed with anti-human PML antibody, mAb PGM3. mAb PGM3 recognizes residues 37 ± 51, the region just N-terminal to the RING. In the bottom panel, lysates were immunoprecipitated with the anti-human PML antibody, mAb 5E10, and blots probed with a polyclonal antibody to PRH. mAb 5E10 recognizes residues 448 ± 466 which is near the NLS of PML. (b) NB4 cell lysates were immunoprecipitated with PRH antibody or IgG either after treatment with retinoic acid or in untreated controls. Subsequent Western blots were probed with mAb PGM3. (c) PRH interacts with both PML-RARA and PML in NB4 cells. Cell lysates were treated with retinoic acid (+RA) or untreated (7RA) and precipitated with the PRH antibody. The Western blot was probed with an antibody to the retinoic acid receptor alpha (RARA; Santa Cruz) showing bands which correspond in size to both PML-RARA and RARA. The RARA antibody recognizes the C-terminus of RARA, residues 443 ± 462. For all experiments IP indicates immunoprecipitated fraction, S supernatant after immunoprecipitation and W sixth wash of immunoprecipitated fraction as described in Materials and methods PRH. Consistent with the above results, PRH copuri®es with PML. For negative controls, precleared lysates were immunoprecipitated with mouse immunoglobulin (IgG), neither PML (Figure 5a ) nor PRH (data not shown) were precipitated.
PRH and PML co-localize in K562 cells
Studies were carried out to demonstrate whether PML and PRH associate in intact cells. As the subcellular distribution of PRH was unknown, we carried out studies to establish the localization of PRH by confocal laser microscopy and immuno¯uorescence. PRH appears as a punctate pattern in both the nucleus and cytoplasm of these cells as seen in (Figure 6a,b) ; additionally, there is a cytoplasmic diuse pattern observed. The adjacent panel shows the phase contrast view which indicates there is some cellular debris due to the cytospin. In separate experiments, cells were stained with a monoclonal antibody to PML, mAb 5E10 (Stuurman et al., 1992) (Figure 6c,d ). PML forms nuclear bodies as expected, but there are fewer than the 10 ± 20 observed in other cell types (Melnick and Licht, 1999) and they appear larger than the PRH bodies.
Experiments were carried out to establish if PML and PRH co-localized ( Figure 6 ). Cells were stained with the PRH polyclonal antibody (E, red), mAb 5E10 (F, green) and the overlay (G, ov) for the image is shown in yellow. A phase contrast image is shown in the adjacent panel (H) which indicates that there is some cellular debris due to the cytospin. The region of co-localization is typically in the center of the bodies, giving a pattern of a yellow dot, where co-localization occurs, surrounded by a larger green area where PML is present. There is a substantial nuclear population of PRH as well as a cytoplasmic population which do not co-localize with PML. In contrast, the majority of PML bodies have PRH associated with them ( Figure  6G ). These data establish that PML and PRH have partially overlapping subnuclear expression patterns in intact cells. Together with the yeast 2-hybrid and immunoprecipitation data, our results indicate that a subset of PML and PRH proteins associate in intact cells.
PRH and PML associate in the APL patient derived cell line NB4
To assess the importance of the PRH-PML interaction in APL, co-immunoprecipitation studies of PRH were undertaken in the APL derived cell line, NB4. NB4 cells express both PML-RARA fusion and wild-type PML proteins. The expression of PML-RARA disrupts nuclear body formation in these cells (Melnick and Licht, 1999) . ATRA treated and untreated NB4 cells were lysed and immunoprecipitated with a polyclonal antibody to PRH and resulting blots probed for PML (mAb PGM3) (Figure 5b) . Results show that PML copuri®es with PRH. Similar results were obtained when lysates were immunoprecipitated with mAb PGM3, which recognizes the N-terminus of PML, and blots probed for PRH (data not shown). PRH co-puri®es with PML regardless of treatment. In negative controls, neither PRH nor PML were precipitated by IgG in ATRA treated (Figure 5b ) or untreated lysates (data not shown).
Since both PML and PML-RARA contain the RING domain, we determined if PRH could bind both proteins. PML-RARA varies in size from 90 ± 120 kDa, depending on the splice variant (Melnick and Licht, 1999) . The RING domain of PML-RARA is degraded after ATRA treatment while the RING of wild-type PML is not (Melnick and Licht, 1999) . Thus, in the above experiments (Figure 5b ), only undegraded PML-RARA will be detected as the degraded form no longer has the epitope recognized by mAb PGM3. Blots were probed with an antibody to RARA ( Figure  5c ). The data indicate that in untreated NB4 cells, PRH immunoprecipitates RARA which is *50 kDa as well as higher migrating species which are PML-RARA. Intervening bands are most likely either splice variants or degradation products occurring during Figure 6 PRH and PML co-localize in K562 cells. Cells were immunostained with PRH antibody in red (A), or anti-human PML antibody, mAb 5E10 in green (C) where the adjacent panels (B, D respectively) show phase contrast views of the same ®eld. The lower panels are images from co-localization experiments where cells were double immunostained with PRH antibody in red (E) and mAb 5E10 in green (F). mAb 5E10 recognizes residues 448 ± 466 of human PML which is near the NLS of PML. The overlay is shown in yellow (G) and the corresponding phase contrast image is shown in (H). The objective is 1006. Further magni®cations were as follows: 1.36 (A,B), 2.16 (C,D) and 1.36 (E ± H). These confocal micrographs represent single slices through the plane of the cells. FITC and Texas Red channels were recorded independently preparation. Higher molecular weight bands were con®rmed to be PML-RARA by probing blots with mAb 5E10, which recognizes an epitope present in both PML-RARA and degraded PML-RARA (Stuurman et al., 1992) . These degraded forms of PML-RARA can associate with full-length PML-RARA and PML through coiled coil interactions (Melnick and Licht, 1999) . Precipitation of RARA by PRH is consistent with previous studies which show PML-RARA associates with RARA (Melnick and Licht, 1999) . After ATRA treatment, PRH no longer precipitates any RARA containing moieties ( Figure  5c ) although it clearly associates with PML ( Figure  5b) . Collectively, the results show that PRH associates with PML-RARA and PML. Further, once the RING of PML-RARA is proteolyzed after ATRA treatment, PRH no longer associates with the fusion protein and is free to associate with wild-type PML. These results are consistent with our yeast 2-hybrid data which showed that an intact RING was required for interaction with PRH (Figure 1) . The result that PRH does not associate with PML-RARA after ATRA treatment may have signi®cant consequences for ATRA induced dierentiation of these cells.
Reports indicate that ATRA can induce degradation not only of PML-RARA but of a fraction of wild-type RARA (Gianni et al., 1998; Shao et al., 1998) . ATRA induces a speci®c cleavage in a fraction of RARA protein. We do not observe this faster migrating species (Figure 5c ) and there does not appear to be any mobility dierences in RARA positive bands between ATRA treated and untreated cells. The antibody used recognizes the C-terminal portion of RARA, therefore we are unable to detect any RARA moieties degraded here. Thus, we may not detect the cleaved product. Because of the possible eects of ATRA on RARA as well as its established eects on PML-RARA, we cannot rule out the possibility that the inability of PRH to precipitate PML-RARA from ATRA treated NB4 cells (Figure 5c , IP lanes) is because of the loss of an association between PRH and RARA. If there is an association between PRH and RARA which is lost in ATRA treated cells, one would expect to see a decrease in the level of immunoprecipitation relative to the levels of RARA degradation. However, we observe a complete loss of association with both RARA and the higher molecular weight PML-RARA components in our experiments with no concomitant increase in degraded RARA or decrease in wild-type RARA present. Further, there is signi®cant RARA in the supernatant lane in the treated cells. For the above reasons in combination with our yeast 2-hybrid, immunoprecipitation and immuno¯uorescence results, we favor the hypothesis that PRH associates with PML-RARA and that this interaction is lost when the N-terminal region of PML-RARA is degraded after ATRA treatment.
PRH associates with PML nuclear bodies in NB4 cells
To con®rm the biological signi®cance of the PML-PRH interaction in NB4 cells, immunolocalization experiments were carried out. Prior to ATRA treatment PML nuclear bodies are disrupted in NB4 cells. To establish the eect of ATRA on PRH localization, immuno¯uorescent confocal laser microscopy experiments were carried out ( Figure 7A1,B1) . In both treated and untreated cells, PRH has a nuclear Figure 7 The distribution of PRH and PML in treated and untreated NB4 cells. NB4 cells were stained with the PRH antibody. Untreated cells (A1, red) and below ATRA treated cells (B1, green) are shown. The corresponding phase contrast images are shown in C1 and D1 respectively. These confocal micrographs represent single slices through the plane of the cells. The objective is 1006. Further magni®cations were as follows: 2.1 (A1,C1) and 1.9 (B1,D1). Experiments were carried out to determine if PML and PRH associate in NB4 cells. NB4 cells were immunostained with the PRH antibody (A, green) and mAb PGM3 (B, red). mAb PGM3 recognizes residues 37 ± 51, the region just N-terminal to the RING of human PML. The overlay is shown in yellow (ov, C) and the corresponding phase contrast view in D. The objective is 1006. Images were further magni®ed by 2.3 times. These confocal micrographs represent single slices through the plane of the cells. FITC and Texas Red channels were recorded independently and a cytoplasmic punctate distribution similar to K562 cells ( Figure 5 ). There is some cellular debris due to the cytospin as seen in the phase contrast images ( Figure 7C1 ,D1). Treatment with ATRA does not signi®cantly alter the distribution of PRH ( Figure  7B1 ). Qualitatively, there appears to be slightly more cytoplasmic PRH present in cells after ATRA treatment.
Typically, PML has a micropunctate pattern in untreated NB4 cells whereas PML nuclear bodies reform after ATRA treatment. Studies were carried out in ATRA treated cells where PML bodies are present. Figure 7 shows staining typical of PML in ATRA treated NB4 cells, PRH is shown in the adjacent panel (B), the overlay (C) is shown in yellow with the corresponding phase contrast view shown in (D). In these experiments, the mAb PGM3 antibody was used so only PML moieties with intact N-termini are detected. PRH and PML appear to co-localize in a subset of bodies. As observed in K562 cells, PML bodies are larger than their PRH counterparts. Similar to K562 cells, co-localization occurs amidst larger PML bodies leading to a pattern of yellow dots surrounded by red. Clearly there are many more PRH bodies than PML, and many of these have no PML associated with them. Conversely, the majority of PML bodies are associated with PRH. Our immunouorescence results taken together with the immunoprecipitation data clearly indicate that PML and PRH are partially co-localized in NB4 cells raising the possibility that this interaction could play a role in leukemogenesis.
Discussion
We report a new partner protein for PML and a novel PML RING binding domain: the homeodomain protein PRH. Conversely, PML and Z are the ®rst protein partners reported for PRH. We show that PML & PRH and Z & PRH interact through yeast 2-hybrid, immunoprecipitation and immuno¯uorescence methods. Our studies in the APL patient cell line NB4 indicate that PRH can bind both PML and PML-RARA. This ®rst report of the subcellular distribution of PRH reveals cytoplasmic and nuclear bodies some of which associate with PML nuclear bodies. Unlike PML, the distribution of PRH is not altered signi®cantly by addition of ATRA to NB4 cells. Similarly, ATRA does not change PRH protein levels (this study) consistent with studies showing no alterations in mRNA levels (Mani®oletti et al., 1995) . The PML PRH interaction has intriguing functional possibilities for PML and APL because of the role PRH plays in hematopoiesis and its interaction with PML-RARA.
Several reported functions of PRH could be important in the pathogenesis of APL. PRH functions in hematopoiesis (Bedford et al., 1993; Mani®oletti et al., 1995) , in development of vascular endothelium and in its maintenance in adults (Newman et al., 1997; Thomas et al., 1998) . PRH overexpression disrupts developing vascular structures and increases the number of vascular endothelial cells (Newman et al., 1997) . Uniquely among the homeobox genes, PRH is expressed in endothelial cells throughout the developing vascular system (Newman et al., 1997) . PRH dysregulation was postulated to contribute to leukemogenesis (Man®oletti et al., 1995; Tanaka et al., 1999) ; we provide the ®rst direct evidence that PRH could contribute to leukemogenesis. Our results suggest that the function of PRH could be disrupted in APL since it binds both PML and prior to ATRA treatment, PML-RARA. Thus PML-RARA sequesters PRH from normal function until it is released by ATRA induced degradation of PML-RARA. This RING dependence is consistent with our yeast 2-hybrid studies. In K562 cells, transfected PML-RARA aects myeloid and erythroid cell dierentiation . Our results suggest that PRH would bind the transfected PML-RARA as well as wild-type PML in these cells. These results raise the possibility that PML through its interaction with PRH may play a role in hematopoiesis and development/ maintenance of the vascular endothelium.
PRH is a member of the orphan cluster of homeodomains (Crompton et al., 1992; Hromas et al., 1993; Bedford et al., 1993) . It binds a known DNA binding sequence and the proline-rich region is not required for this activity (Crompton et al., 1992) . PRH represses luciferase protein production when fused to the GAL4 DNA binding domain suggesting that PRH could function as a negative transcriptional regulator (Tanaka et al., 1999) . In these studies, luciferase mRNA levels were not monitored so whether PRH acts solely at the transcriptional level was not established. Our immunocytochemistry studies indicate that PRH is found in the nucleus and cytoplasm in the two cell lines investigated. The signi®cant cytoplasmic PRH suggests that PRH may have functions in addition to transcription. Studies indicate that PML can repress protein production through its ability to bind translation factors and to modulate mRNA transport (Lai and Borden submitted). Thus, PRH, like PML, may act post-transcriptionally. Consistently, other homeodomain proteins are able to modulate both transcription and translation (May®eld, 1996) .
We show that PRH and PML associate through functional domains implying that each can alter the action of the other. The proline-rich regions (amino acids 45 ± 136) required for repression (Tanaka et al., 1999) and for PML and Z binding (amino acids 50 ± 115) overlap. These results suggest that PML and Z could modulate the repression actions of PRH. Although, there is a signi®cant distribution of PRH in the cytoplasm, the presence of the homeodomain strongly suggests that PRH can act directly in transcription. Our preliminary data suggest that PML enhances the repression action of PRH (Melnick and Borden, unpublished results). These data suggest that the interaction between PML and PRH is a functionally relevant one.
Conversely, PRH binds the RING domains of both PML and Z. The RING is required for the growth suppressor, transformation suppressor and apoptotic actions of PML (Melnick and Licht, 1999) . Hence, PRH likely aects these RING mediated functions. Collectively, these results suggest that in cells expressing both of these proteins, hematopoiesis, growth and apoptosis could be linked through the PRH PML interaction. The association of PRH with PML-RARA suggests that PRH may modulate the transcriptional activity of the fusion protein. Previous studies indicate that PML-RARA has transcriptional actions through its RARA moiety, PML-RARA homodimers are detected as distinct DNA binding species and associate with RAREs more tightly than RAR/RXR heterodimers (Melnick and Licht, 1999) . After ATRA treatment and degradation of the PML moiety, the degraded form of PML-RARA consists mainly of RARA and acts similarly to RARA (Melnick and Licht, 1999) . The loss of PRH association with PML-RARA after ATRA induced degradation may contribute to the dierences observed in DNA binding speci®cities and transcriptional actions of PML-RARA versus RARA.
In this report we show in cell culture that PRH associates with a subset of PML bodies. PML bodies are heterogeneous where the presence of some components relies on cell cycle, stress and other factors (Melnick and Licht, 1999) . Some PML partners localize with all bodies whereas others only associate with a subset. For instance, detection of CBP protein association with PML by immuno¯uorescence is dependent on the CBP antibody used (Doucas et al., 1999) . Because the PRH antibody used is in the proline rich region, it is possible that similar to CBP, PRH is detected in only a subset of bodies because the epitope is masked. Another possibility is that the association of PRH with PML may be a temporal one. Alternatively, there may be potential subdomains or components of PML bodies which must be present for PRH association or conversely, certain components may block association so PRH is found in bodies where these components are absent. None of these possibilities are mutually exclusive and may all contribute to the pattern of localization observed for PRH and PML.
The RING domain mediates protein interaction and mutations which disrupt subsequent interactions are oncogenic in several proteins including BRCA1 and PML. This family is diverse in terms of both sequence homology and three-dimensional structure (Borden, 1998; . The RING binds two zinc atoms per molecule in a conserved cross-brace motif. The structure around the ®rst zinc binding site is highly conserved whereas structure and spacing are not highly conserved around the second zinc binding site (Borden, 1998) . A major goal of this study was to ®nd RING binding domains (RBD) for PML in the hopes that this may lead to a molecular understanding of the oncogenic potential of the RING. The other RBD reported for PML is PIC1/Sentrin/Sumo-1 a ubiquitin like molecule which is covalently attached to the RING (Melnick and Licht, 1999) . We have identi®ed at least part of a novel RBD for PML in the proline-rich region of PRH. This region is required for binding of not only PML but also of Z. The point mutations which abrogated association were in the conserved zinc binding site 1 for both PML and Z. Dierences in sequence patterns around zinc binding site 2 suggest that PML and Z are not structurally homologous in this region but one would predict similar structures around site 1. Thus, it is more likely that PML and Z would recognize PRH through the conserved site 1. Given the high degree of structural conservation of zinc binding site 1, other RING proteins may bind similar proline-rich regions. Consistent with this possibility, the two zinc binding sites of BRCA1 RING may bind partner proteins independently of the integrity of the other site (Meza et al., 1999) . RBDs reported appear to be speci®c to certain RINGs where RINGs from other proteins are unable to interact. Alternatively, certain RING proteins bind selected RING proteins through their respective RINGs (Tanimura et al., 1999; Meza et al., 1999) . Outside of RING RING interactions, the proline-rich region of PRH is the ®rst RBD that recognizes more than one RING. The proline-rich region of PRH is distinct from other RBDs in terms of sequence homology. Further studies will be needed to ascertain if this proline-rich region could represent a universal RBD.
We show that the viral protein Z associates with PRH similarly to PML suggesting that during infection PRH functions would be impaired. The virus is a member of the arenavirus family which includes known human pathogens such as Lassa fever virus and Bolivian hemorrhagic fever virus (Salvato and Rai, 1996) . The Z proteins in this viral family are highly homologous suggesting that other family members will bind PRH. Intriguingly, the tissues in which PRH is most highly expressed lung, liver and myeloid cells (Crompton et al., 1992; Thomas et al., 1998) , are the major target organs for arenavirus infection (Salvato and Rai, 1996) . The hemorrhagic fever disease associated with this family of viruses is typi®ed by a leaky vasculature and thrombocytopenia (Salvato and Rai, 1996) . Recent studies revealed a role in formation and maintenance of the vascular endothelium for PRH. The association of Z and PRH and the ability of Z to translocate PML bodies to the cytoplasm suggest that normal PRH function may be disrupted during infection. PRH is the ®rst host cell protein associated with an arenavirus protein which could explain the hemorrhagic symptoms observed during infection. The ability of Z to bind and disrupt PRH function is a possible mechanism for the molecular pathogenesis of these types of hemorrhagic diseases.
Dierentiation and proliferation are thought to be mutually exclusive processes. Leukemias arise when both processes are disrupted. The paradigm for leukemogenesis in APL is that disruption of PML alters growth inhibition and apoptosis and disruption of RARA alters dierentiation (Melnick and Licht, 1999) . The PML and PRH interaction through functionally active domains and the inclusion of PRH in some PML nuclear bodies raises the possibility that PML may function in hematopoiesis in cell types which express PRH as well as function in growth control. PML's eect on cell survival coupled with PRH's eect on myeloid cell development suggest that these proteins are positioned to function in both growth control and dierentiation. Disruption of PML in APL and the ability of PRH to bind PML-RARA raises the possibility that PRH as well as PML dysfunction contributes to leukemogenesis in APL.
Materials and methods

Recombinant DNA
Full-length human PML and Z cDNA were described (Borden et al., 1995 (Borden et al., , 1998a and cloned into constructs with the GAL4 DNA binding domain (pAS-PML and pAS-Z) in order to carry out yeast 2-hybrid studies. Double point mutations in the RING domains of PML and Z which abrogate zinc binding and therefore folding of the RING were described (Borden et al., 1995 (Borden et al., , 1998a . Deletion mapping of PML including the deletion of the B-boxes (PML-Bbox, nucleotides 420 ± 802), leucine coil (PML-coil, 660 ± 1003), and C-terminal domains (PML-Xma, 1360 ± 1693 and PML-Cterm, 880 ± 1648) are described (Borden et al., , 1998a , these constructs were subcloned into the pAS vector for yeast 2-hybrid studies. Digestion of the pACT-PRH construct with SacII results in the deletion of nucleotides 160 ± 345 in the proline rich region of PRH (PRH-pro).
The mammalian expression construct, pcDNA3.1-PRH, was sequenced to con®rm no mutations occurred during subcloning and had a FLAG tag.
Cell culture
HeLa cells were used for transient transfection studies. Cells were transfected using superfect (Qiagen). These cells were grown in DMEM and 10% FCS (Gibco). K562 and NB4 cells were grown in suspension in RPMI and 10% FCS. For immuno¯uorescence studies, cells were cytospun onto histological slides. When indicated, NB4 cells were treated with 1 mM of all trans retinoic acid (ATRA, Sigma) for 2 days before they were harvested for further studies.
Yeast 2-hybrid studies
This system was used to screen *10 6 individual clones of a K562 derived cDNA library (Clonetech) fused to the activation domain of GAL4 against pAS-Z. Standard protocols were used for the screening, transfection and analysis (Fields and Song, 1989; Durfee et al., 1993; Guthrie and Fink, 1991) . cDNAs are cloned unidirectionally in this library. Wild-type and mutant PRH, PML and Z cDNA constructs in pAS or pACT were transformed into the s. cervisiae strain HF7c. Quantitative analyses were carried out in the PJ69 strain. Unless stated, none of the wild-type or mutant constructs used in these studies autoactivated. After transformation, yeast were plated onto SC media lacking Trp, Leu and His and including 30 mM 3-aminotriazole. Plates were incubated at 308C for 3 ± 5 days. Colonies were transferred to nitrocellulose ®lters (Amersham), and permeabilized with liquid nitrogen. Standard procedures were used to determine b-galactosidase activity. The primary library screen gave three positive interaction clones. These clones were sequenced using standard methods. Quantitative bgalactosidase tests using o-nitrophenyl-b-D-galactosidase (ONPG) were carried out (Miller, 1972) . Experiments were carried out in triplicate where means and s.d. are reported.
PRH antibody
The PRH antibody was raised in rabbits against a peptide corresponding to residues 118 ± 135 of the whole PRH protein using standard procedures.
PML antibodies
PML antibodies include a monoclonal antibody to the human form of PML, mAb 5E10 (Stuurman et al., 1992) which recognizes residues 448 ± 466 (Terris et al., 1995) or a monoclonal antibody to the N-terminal region of human PML which recognizes residues 37 ± 51 (Santa Cruz, mAb PGM3).
Immuno¯uorescence and confocal laser microscopy studies
Our immuno¯uorescence methods were adapted from Harlow and Lane (1988) and as described (Borden et al., 1998b . In experiments with K562 and NB4 cells, PML monoclonal antibodies, mAb 5E10 or mAb PGM3, were used at a dilution of 1 : 200 and the PRH polyclonal antibody was used at a dilution of 1 : 200 and detected using appropriate¯uoroscein isothioconjugate (FITC) or Texas Red (Jackson Immunoresearch) secondary antibodies as indicated. Fluorescence was observed using a confocal laser microscope (Leica) with excitation recorded at 568 nm (red) or 488 nm (green). The two channels were recorded independently to avoid cross-talk. The pinhole was set to 20. Under these conditions, there was no breakthrough of FITC signal into the red channel or vice versa. Each confocal experiment was performed at least twice and the number of cells in each sample exceeded 500. Images were overlaid in Photoshop.
Co-immunoprecipitation studies
Protein ± protein interactions were demonstrated by coimmunoprecipitation assays. Experiments were carried out according to (Carlile et al., 1998) . Cell lysates were mixed with the appropriate antibody: PRH polyclonal antibody, mAb 5E10, mAb PGM3, HA (Santa Cruz) or mouse immunoglobulin, IgG (Calbiochem). These antibodies were covalently bound to protein A sepharose beads as described (Borden et al., 1998b; Carlile et al., 1998) . PML and PRH were immunoprecipitated from K562 and NB4 cells in separate experiments. Total cell lysates were precleared twice as described (Carlile et al., 1998) . Protein A-antibody beads were added to precleared supernatants and mixed for 2 h at 48C. Beads were washed three times with IPB buer (150 mM NaCl, 20 mM Tris-HCl pH 7.4, 1% Nonidet P40, 100 mM PMSF, and 5 mg/ml of leupeptin, pepstatin A and aprotinin) and three times with modi®ed IPB buer (0.1% deoxycholate and no Nonidet P40). Beads were spun, collected and an equal volume of reducing sample buer was added in preparation for SDS ± PAGE. Subsequently, samples were blotted (Western method) onto Immobolin P membranes, using ECL (Amersham) to visualize the bound antibodies. The blots were probed with either PML (mAb PGM3 or mAb 5E10 as indicated), PRH, or FLAG antibodies or with an antibody to RARA (C20, Santa Cruz), which recognizes the C-terminus so is present in both RARA and PML-RARA.
Immunopuri®cation of PRH from yeast lysates
Yeast transformed with the pACT-PRH construct were lysed using sonication. Yeast extracts were precleared with mouse IgG protein A beads. The precleared supernatant was placed into a fresh tube and HA protein A sepharose beads were added. An aliquot of the HA-PRH beads was subjected to SDS ± PAGE and indicated that the PRH was pure by Coomassie blue staining. For a negative control, protein A beads with HA antibody conjugated but no PRH were added. The IP was carried out in the presence of bovine serum albumin (BSA, 0.5 mg/ml), 1% NP-40, and Z protein for 2 h at 48C. See the co-immunoprecipitation section for more details. The precipitates, post precipitated supernatants and washes were subjected to SDS ± PAGE and gels were stained with Coomassie blue.
